U.S. Healthtech Stock News

If you are wondering whether Bandwidth, at a last close of US$44.86, still offers value after a strong run, the key question is how its current price lines up with its underlying fundamentals. The stock has recorded returns of 86.0% over 7 days, 150.2% over 30 days, 215.5% year to date and 259.2% over 1 year, while the 5 year return sits at a 64.3% decline and the 3 year return is 289.7%. Recent share price moves have come alongside ongoing interest in cloud based communications and software...

For investors considering whether Guardant Health at around US$87.60 represents fair value or a potential opportunity, this article examines what that price may indicate about the stock. The share price is US$87.60 after a 1.5% decline over the past week and a 3.9% decline over the past month. It is still up 87.0% over the past year and 270.4% over three years, while a 35.3% decline over five years provides additional context. Recent news about Guardant Health has highlighted its role in...

IDEAYA Biosciences (IDYA) is back in focus after the FDA agreed to review its New Drug Application for darovasertib plus crizotinib in first line metastatic uveal melanoma under a Real-Time Oncology Review program. See our latest analysis for IDEAYA Biosciences. Even with the FDA review decision and recent positive Phase 2/3 data, IDEAYA Biosciences’ share price has pulled back, with a 30 day share price return of a 13.21% decline and a year to date share price return of a 16.72% decline,...

Wondering whether Sportradar Group's current share price reflects its true worth, or if the market is mispricing the story. The stock last closed at US$13.26, with returns of 0.2% over 7 days, a 20.3% decline over 30 days, and year to date and 1 year returns of 43.1% and 44.1% declines, while the 3 year return sits at 1.8%. Recent coverage has focused on Sportradar Group as a listed sports data and technology provider, with attention on how it is positioned in the wider sports betting and...

Why TriNet Group is on investors’ radar today TriNet Group (TNET) has drawn attention after a period of mixed share performance, with a strong month and past week set against weaker returns over the past 3 months and year. See our latest analysis for TriNet Group. At a share price of US$44.47, TriNet Group’s recent 24% 30 day share price return contrasts with a 27% 90 day share price decline and a 44% 1 year total shareholder return loss, suggesting fading longer term momentum despite the...

Wondering if American Electric Power Company at about US$136.91 is offering fair value or if you might be paying over the odds? This article breaks down what the current pricing could mean for you. The stock last closed at US$136.91, with returns of 1.6% over 7 days, 4.0% over 30 days, 18.2% year to date, 31.4% over 1 year, 66.4% over 3 years, and 86.7% over 5 years. This provides useful context before assessing any valuation metrics. Recent trading interest has been shaped by ongoing...

APA stock performance snapshot APA (APA) has drawn fresh attention after recent trading, with the share price closing at US$40.13. The stock shows mixed short term moves, including a 1.5% decline over the past day and a 6.4% gain over the past week. See our latest analysis for APA. The recent 6.4% 7 day share price return, alongside a 90 day share price return of 51.9% and a 1 year total shareholder return of 154.0%, points to strong momentum despite short term pullbacks. If APA’s move has...

First Industrial Realty Trust expanded its board and appointed Frank E. Schmitz as an independent director. The move follows a recent activist investor campaign focused on board composition and governance. The appointment comes in a contested board setting, signaling a response to shareholder pressure. For investors watching NYSE:FR, this board change occurs at a time when the stock is trading at $62.14 and has returned 31.2% over the past year and 44.6% over the past five years. Those...

Gen Digital (NasdaqGS:GEN) has partnered with xAI to bring Grok large language models into its consumer platforms via the Gen AI Foundry. The company is launching VPN for Agents, presented as an industry first security tool tailored to autonomous AI agents. Gen Digital is also expanding Norton AI Agent Protection to address new cyber risks created by AI driven agents. Gen Digital, trading at $19.37, is adding these AI focused efforts on top of a share performance record that includes a...

Ultra Clean Holdings (NasdaqGS:UCTT) announced that Clarence Granger will step down as Chairman of the Board effective May 22, 2026. Tom Edman has been appointed to assume the Chairman role as the company adjusts its leadership at the board and executive levels. This change follows a period of executive transitions while the sector is influenced by increased AI related investment. Ultra Clean Holdings, trading at $74.61, has seen sharp share price moves recently, including a 10.1% decline...

In late April 2026, TTM Technologies reported record first-quarter 2026 results with net sales of US$845.98 million and net income of US$49.99 million, and issued second-quarter guidance calling for net sales between US$930 million and US$970 million. The company highlighted that robust demand tied to artificial intelligence data center buildouts and defense-related programs now underpins the majority of its revenue base, supporting record non-GAAP earnings and higher capital investment...

Relay Therapeutics (RLAY) has drawn fresh attention after deciding to advance zovegalisib plus Pfizer’s atirmociclib into Phase 3 for PI3Ka-mutated, HR+/HER2- metastatic breast cancer, following early safety and response data in heavily pre-treated patients. See our latest analysis for Relay Therapeutics. The share price has been volatile around the latest zovegalisib update, with a 7 day share price return of negative 15.9%, following a 90 day share price return of 66.1% and a 1 year total...

Q1 results and digital-first push in focus for OFG Bancorp (OFG) OFG Bancorp (OFG) has been in focus after first quarter results topped Wall Street expectations, with management pointing to ongoing loan growth, steady credit performance, and disciplined expense management. See our latest analysis for OFG Bancorp. The share price has gained 11.3% over the past month and 13.5% over the past quarter. The 1 year total shareholder return of 13.8% and 3 year total shareholder return, which is about...

Beyond Meat recently expanded its retail footprint by rolling out Beyond Chicken Pieces Spicy Buffalo to more than 2,000 Kroger stores across the U.S., while the U.S. Army signaled interest in plant-based proteins for future field rations. These developments highlight how product innovation and potential government demand could interact with Beyond Meat’s existing efforts to refine its portfolio and operations. We’ll now examine how the U.S. Army’s interest in plant-based protein could...

Recent trading in PHINIA (PHIN) has drawn attention after the stock’s 1 year total return reached 80.31%, prompting investors to look more closely at its current valuation, profitability, and growth profile. See our latest analysis for PHINIA. At a share price of $74.02, PHINIA’s recent 1 month share price return of 6.32% and year to date share price return of 14.49% sit alongside a 1 year total shareholder return of 80.31%. Investors are now weighing this momentum against its valuation and...

In April 2026, Range Resources reported first-quarter 2026 results showing daily production of about 1,508,842 Mcf of natural gas, 108,193 barrels of NGLs, 8,239 barrels of oil and total revenue of US$1,034.17 million, with net income of US$341.63 million and diluted EPS of US$1.44 from continuing operations. Alongside these stronger operational and financial results, new Schedule 13G filings reveal that Vanguard entities have built passive stakes above 5% of Range Resources’ outstanding...

If you are wondering whether Arrowhead Pharmaceuticals' current share price lines up with its fundamentals, this article walks through the key valuation angles that matter to you. The stock last closed at US$74.81, with returns of 1.2% over 7 days, 18.9% over 30 days, 10.4% year to date, 418.8% over 1 year and 80.8% over 3 years, compared with 12.7% over 5 years. Recent market focus around Arrowhead Pharmaceuticals has centred on its position in the biopharmaceutical space and ongoing...

Operational momentum behind recent price move Hecla Mining (HL) recently drew investor attention after a very large year over year jump in earnings per share and a 79.5% rise in quarterly revenue, alongside higher next quarter EPS estimates. See our latest analysis for Hecla Mining. Despite the latest 0.22% 1-day share price return and recent short-term weakness, Hecla Mining’s very large 1-year total shareholder return of 298.47% signals that momentum has been building over a longer...

Recent analyst upgrades and favorable momentum scores have put Perimeter Solutions (PRM) back on many watchlists, with positive earnings estimate revisions and strong industry relative share performance drawing fresh attention from investors. See our latest analysis for Perimeter Solutions. The recent 17.74% 1 month share price return, together with a very large 1 year total shareholder return of around 3x, suggests momentum is building as investors reassess Perimeter Solutions at a last...

In recent months, CleanSpark reported rapid growth in Bitcoin mining output, expanded its hashrate to 50 EH/s, and closed the acquisition of a second Texas data center campus adding 300 megawatts of power capacity to support both mining and AI or cloud workloads. An interesting angle for investors is how CleanSpark is using cash flow from Bitcoin mining to build a Bitcoin treasury while reinvesting into power-heavy data center infrastructure that can serve high-performance computing demand...

In late April 2026, Johnson & Johnson reported strong first‑quarter results with revenue of US$24.06 billion, raised its full‑year sales outlook to US$100.30–US$101.30 billion, increased its quarterly dividend to US$1.34 per share, and advanced key therapies including IMAAVY (nipocalimab) receiving FDA Priority Review in warm autoimmune hemolytic anemia and CAPLYTA (lumateperone) gaining an expanded label for preventing schizophrenia relapse. These moves highlight Johnson & Johnson’s effort...

If you are wondering whether New Jersey Resources at around US$56 is offering good value today, it helps to step back and look at what the recent price and fundamentals are really telling you. The stock has recently closed at US$56, with returns of 0.3% over 7 days, 1.8% over 30 days, 21.8% year to date, 17.6% over 1 year, 23.4% over 3 years, and 54.5% over 5 years. This gives plenty of data points to weigh up how the market currently views its prospects and risks. Recent coverage around New...

Why Invesco’s latest quarter matters for shareholders Invesco (IVZ) just reported first quarter 2026 results, with revenue of US$1,744.5 million and net income of US$268.6 million, alongside continued net long term inflows and record assets under management in China. See our latest analysis for Invesco. At a share price of US$25.89, Invesco’s recent 6.46% 1 month share price return and 1.49% 7 day gain contrast with a weaker 90 day share price return of 5.13% and a year to date share price...

Context for Helios Technologies after recent performance Helios Technologies (HLIO) has drawn renewed investor interest after a recent period where the stock showed mixed moves, with a 2.3% decline over the past week and a 2.2% decline over the past month. See our latest analysis for Helios Technologies. Despite the recent soft patch in the share price, with a 30 day share price return of a 2.18% decline, momentum over a longer window still reflects a 22.17% year to date share price gain and...